Show simple item record

dc.contributor.authorTzafriri, A. R.
dc.contributor.authorLevin, A. D.
dc.contributor.authorEdelman, Elazer R.
dc.date.accessioned2012-12-12T15:45:11Z
dc.date.available2012-12-12T15:45:11Z
dc.date.issued2009-03
dc.date.submitted2008-07
dc.identifier.issn0960-7722
dc.identifier.issn1365-2184
dc.identifier.urihttp://hdl.handle.net/1721.1/75407
dc.description.abstractBackground:  Local drug delivery has transformed medicine, yet it remains unclear how drug efficacy depends on physicochemical properties and delivery kinetics. Most therapies seek to prolong release, yet recent studies demonstrate sustained clinical benefit following local bolus endovascular delivery. Objectives:  The purpose of the current study was to examine interplay between drug dose, diffusion and binding in determining tissue penetration and effect. Methods:  We introduce a quantitative framework that balances dose, saturable binding and diffusion, and measured the specific binding parameters of drugs to target tissues. Results:  Model reduction techniques augmented by numerical simulations revealed that impact of saturable binding on drug transport and retention is determined by the magnitude of a binding potential, Bp, ratio of binding capacity to product of equilibrium dissociation constant and accessible tissue volume fraction. At low Bp (< 1), drugs are predominantly free and transport scales linearly with concentration. At high Bp (> 40), drug transport exhibits threshold dependence on applied surface concentration. Conclusions:  In this paradigm, drugs and antibodies with large Bp penetrate faster and deeper into tissues when presented at high concentrations. Threshold dependence of tissue transport on applied surface concentration of paclitaxel and rapamycin may explain threshold dose dependence of in vivo biological efficacy of these drugs.en_US
dc.description.sponsorshipHertz Foundationen_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (R01 G 49039)en_US
dc.description.sponsorshipJohnson & Johnson. Pharmaceutical Research & Development (Cordis)en_US
dc.language.isoen_US
dc.publisherWiley Blackwellen_US
dc.relation.isversionofhttp://dx.doi.org/10.1111/j.1365-2184.2009.00602.xen_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alike 3.0en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.sourcePMCen_US
dc.titleDiffusion-limited binding explains binary dose response for local arterial and tumour drug deliveryen_US
dc.typeArticleen_US
dc.identifier.citationTzafriri, A. R., A. D. Levin, and E. R. Edelman. “Diffusion-limited Binding Explains Binary Dose Response for Local Arterial and Tumour Drug Delivery.” Cell Proliferation 42.3 (2009): 348–363.en_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.mitauthorTzafriri, A. R.
dc.contributor.mitauthorLevin, A. D.
dc.contributor.mitauthorEdelman, Elazer R.
dc.relation.journalCell Proliferationen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsTzafriri, A. R.; Levin, A. D.; Edelman, E. R.en
dc.identifier.orcidhttps://orcid.org/0000-0002-7832-7156
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record